Kaiming Luo

493 total citations
12 papers, 297 citations indexed

About

Kaiming Luo is a scholar working on Molecular Biology, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kaiming Luo has authored 12 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kaiming Luo's work include MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers) and Cancer-related molecular mechanisms research (3 papers). Kaiming Luo is often cited by papers focused on MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers) and Cancer-related molecular mechanisms research (3 papers). Kaiming Luo collaborates with scholars based in China and Sweden. Kaiming Luo's co-authors include Feng Zhi, Lian Xue, Nan Shao, Yi Ding, Rong Wang, Qing Lan, Rong Wang, Fei Hua, Yujiao Yang and Guanghua Luo and has published in prestigious journals such as Journal of Virology, Molecular Cancer Therapeutics and Frontiers in Pharmacology.

In The Last Decade

Kaiming Luo

12 papers receiving 295 citations

Peers

Kaiming Luo

EPIDE

IMMUN

CCM

Zhi Hao Kwok Singapore

Baijun Bao China

Wenkai Zhou China

Gabriel Adelman Cipolla Brazil

Erdong Shen China

Ida Russo Italy

Zhichen Wei China

Carla Cossu Italy

Zahra Saadatian Iran

Zhi Hao Kwok Singapore

Kaiming Luo

365 ×1.6

280 ×1.4

27 ×0.8

EPIDE

33 ×1.5

IMMUN

18 ×0.9

CCM

Citations per year, relative to Kaiming Luo Kaiming Luo (= 1×) peers Zhi Hao Kwok

Countries citing papers authored by Kaiming Luo

Since Specialization

Citations

This map shows the geographic impact of Kaiming Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaiming Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaiming Luo more than expected).

Fields of papers citing papers by Kaiming Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaiming Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaiming Luo. The network helps show where Kaiming Luo may publish in the future.

Co-authorship network of co-authors of Kaiming Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Kaiming Luo. A scholar is included among the top collaborators of Kaiming Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaiming Luo. Kaiming Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Du, Ke, et al.. (2024). Mitigating bisphenol A-induced apoptosis in KGN cells: the therapeutic role of 1,25-dihydroxyvitamin D3 through upregulation of PGC-1α expression and inhibition of the mitochondrial cytochrome c pathway. HORMONES. 23(3). 363–374. 2 indexed citations

Yuan, Xin, Kaiming Luo, Xiaohong Jiang, et al.. (2023). 1,25-Dihydroxyvitamin D inhibits hepatic diacyglycerol accumulation and ameliorates metabolic dysfunction in polycystic ovary syndrome rat models. Frontiers in Pharmacology. 14. 1077014–1077014. 2 indexed citations

Huang, Jinxin, Fei Hua, Xiaohong Jiang, et al.. (2023). Effects of dulaglutide combined with insulin degludec on glucose fluctuations and appetite in type 2 diabetes. Frontiers in Endocrinology. 14. 1130470–1130470. 1 indexed citations

Du, Ke, et al.. (2023). 1,25-Dihydroxyvitamin D3 alleviates hyperandrogen-induced ferroptosis in KGN cells. HORMONES. 22(2). 273–280. 16 indexed citations

Jiang, Shuai, et al.. (2022). Association Of Blood Lipocalin-2 Levels with Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis. Hormone and Metabolic Research. 54(10). 677–685. 8 indexed citations

Zhi, Feng, Yi Ding, Rong Wang, et al.. (2021). Exosomal hsa_circ_0006859 is a potential biomarker for postmenopausal osteoporosis and enhances adipogenic versus osteogenic differentiation in human bone marrow mesenchymal stem cells by sponging miR-431-5p. Stem Cell Research & Therapy. 12(1). 157–157. 80 indexed citations

Xiang, Shoukui, et al.. (2020). Circular Rna Hsa_Circ_0001445 in Plasma As A Novel Biomarker for Osteoporosis in Postmenopausal Women. Biomarkers in Medicine. 14(16). 1599–1607. 14 indexed citations

Deng, Danni, Kaiming Luo, Hongmei Liu, et al.. (2019). p62 acts as an oncogene and is targeted by miR-124-3p in glioma. Cancer Cell International. 19(1). 280–280. 34 indexed citations

Shao, Nan, Lian Xue, Rong Wang, et al.. (2018). miR-454-3p Is an Exosomal Biomarker and Functions as a Tumor Suppressor in Glioma. Molecular Cancer Therapeutics. 18(2). 459–469. 81 indexed citations

10.

Yu, Miaomei, et al.. (2018). miR-10b Downregulated by DNA Methylation Acts as a Tumor Suppressor in HPV-Positive Cervical Cancer via Targeting Tiam1. Cellular Physiology and Biochemistry. 51(4). 1763–1777. 24 indexed citations

11.

Yu, Miaomei, Shuang Yao, Kaiming Luo, et al.. (2017). Apolipoprotein M increases the expression of vitamin D receptor mRNA in colorectal cancer cells detected with duplex fluorescence reverse transcription-quantitative polymerase chain reaction. Molecular Medicine Reports. 16(2). 1167–1172. 14 indexed citations

12.

Yang, Chunfu, Nining Guo, Kaiming Luo, et al.. (2015). Type I Interferons Triggered through the Toll-Like Receptor 3–TRIF Pathway Control Coxsackievirus A16 Infection in Young Mice. Journal of Virology. 89(21). 10860–10867. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact